Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial

By sjmartinez • August 31, 2023

Moser CB, Chew KW, Ritz J, Newell M, Javan AC, Eron JJ, Daar ES, Wohl DA, Currier JS, Smith DM, Hughes MD; ACTIV-2/A5401 Study Team. Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial. J Infect Dis. 2023 Aug 31;228(Supplement_2):S92-S100. doi: 10.1093/infdis/jiad209. PMID: 37650234.

Tags: adaptive platform trials, covid-19, Harbor UCLA, Infectious Diseases, pooled placebo, Publications, randomization

The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment

Cosgrove SE, Miller LG. The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment? JAMA Netw Open. 2024 Dec 2;7(12):e2451300. doi: 10.1001/jamanetworkopen.2024.51300. PMID: 39705037.

Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2

Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A, Ritz J, Moser C, Eron JJ, Wohl D, Currier J, Daar ES, Greninger A, Klekotka[...]

NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA)

Ersoy SC, Madrigal SL, Proctor RA, Chambers HF, Xiong YQ, Bayer AS. NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus[...]